Richard O'Connor
Roswell Park · Roswell Park Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
3
all conditions, ClinicalTrials.gov
NIH grants tied to them
9
3 more share only the name and are not shown
Trial papers
91
PubMed author-name match
Trials
Studies that name Richard O'Connor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:00 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07102082 · Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product DemandRoswell Park Cancer Institute · recruiting · Smoking Behaviors · principal investigator
- N/ANCT05876091 · Effects of Tobacco Flavoring and Liquid Composition on Vaping TopographyRoswell Park Cancer Institute · terminated · Tobacco-Related Carcinoma · principal investigator
- N/ANCT04744285 · Effects of Filter Ventilation and Ventilation Information on Product Use Behaviors in Cigarette SmokersRoswell Park Cancer Institute · completed · Cigarette Smoking-Related Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Assessing the impact of the substantial equivalence mechanism on the cigarette and cigar marketsR01CA298812 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2025 to 2026 · $822,602 awarded in 2026Same name and institution; not confirmed by an ID
- Assessment of consumer response to smokeless tobacco modified risk marketing ordersR21CA289541 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2024 · $443,509 awarded in 2024Grant number is on one of their registry trials
- WNY Center for Research on Flavored Tobacco Products (CRoFT)U54CA228110 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2018 to 2022 · $3,974,603 awarded in 2022Grant number is on one of their registry trials
- Project 4: Effects of cigarette filter ventilation on cigarette appeal and preferences for combusted and noncombusted tobacco productsP01CA217806 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2017 to 2021 · $494,704 awarded in 2021Grant number is on one of their registry trials
- Emerging Chemicals of Concern in Evolving Electronic Nicotine Delivery SystemsR21ES030028 · NIEHS · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2019 · $210,057 awarded in 2019Same name and institution; not confirmed by an ID
- Influence of advertising and product type on e-cigarette demand among smokersR21DA036476 · NIDA · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2013 to 2014 · $176,527 awarded in 2014Same name and institution; not confirmed by an ID
- Exploring current smokers? interest in using smokeless tobacco productsR01CA141609 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2009 to 2013 · $442,045 awarded in 2013Same name and institution; not confirmed by an ID
- Objective imaging-based assessment of smoking behavior from used filtersR21CA160825 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2011 to 2012 · $195,788 awarded in 2012Same name and institution; not confirmed by an ID
- Evaluating Low Ignition Propensity Cigarette LegislationR01CA117108 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2006 to 2009 · $180,952 awarded in 2009Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:00 UTC. The ranking covers the 200 most relevant of 91 PubMed records, and a shared surname and initials can bring in a namesake. All 91 on PubMed
- Effect of combined maternal and infant food-allergen avoidance on development of atopy in early infancy: a randomized study.J Allergy Clin Immunol · 1989324 citationsRCR 14.2
- Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells.Cancer Immunol Res · 2018281 citationsRCR 8.1
- A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study.Int Clin Psychopharmacol · 2002169 citationsRCR 5.9
- A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia.J Clin Psychiatry · 2002117 citationsRCR 4.1
- Studies on Rh prophylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus.Transfusion · 1971113 citationsRCR 4.3
- Reduction of environmental tobacco smoke exposure among asthmatic children: a controlled trial.Chest · 1994112 citationsRCR 5.4
- Tympanostomy tubes and developmental outcomes at 9 to 11 years of age.N Engl J Med · 2007102 citationsRCR 3.5
- Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience.Urology · 200497 citationsRCR 3.6
- A randomized controlled trial of ultrasound-assisted lumbar puncture.J Ultrasound Med · 200797 citationsRCR 4.4
- Home-based Computer Assisted Arm Rehabilitation (hCAAR) robotic device for upper limb exercise after stroke: results of a feasibility study in home setting.J Neuroeng Rehabil · 201469 citationsRCR 3.8